MRO Acquires Enterprise Clinical Data Management Platform Q-Centrix
Establishing a category defining clinical data solution to fuel innovation, enhance patient care, and improve operational efficiencies in healthcare NORRISTOWN,...
Staff
Karmanos Cancer Institute Continues Community Education Series in June: Understanding Lung Cancer Diagnosis and Treatment Options
The Community Conversations on Cancer seminar series, in partnership with the Detroit Public Library, allows Michigan residents to learn from...
Dotmatics Launches BioGlyph Luma to Accelerate the Future of Protein Design & Engineering
New protein-design & engineering solution enables the first step in Dotmatics' end-to-end scientific intelligence vision—accelerating multimodal R&D with connected, data-driven...
Cosmetic & Reconstructive Dentistry Sets the Standard for Dental Care with Cutting-Edge Technology in Fairfield, CT
FAIRFIELD, Conn., June 12, 2025 /PRNewswire/ -- Cosmetic & Reconstructive Dentistry, led by Dr. Donald Miller, is redefining dental care...
Ellipsis Health unveils Sage, the emotionally intelligent AI Care Manager, backed by $45M from Salesforce, Khosla Ventures, and CVS Ventures
SAN FRANCISCO, June 12, 2025 /PRNewswire/ -- Ellipsis Health, the pioneer in emotionally intelligent AI for healthcare, today announced the...
Cigna Healthcare Unveils Industry-Leading AI-Powered Digital Tools for a Simple and Reliable Customer Experience
New features blend innovation, responsible AI, and human interactions to better support customers in their health care journeysAs new data...
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements
1-for-60 reverse stock split to become effective as of the opening of trading on June 16, 2025 Rutherford, NJ, June...
Sharecare introduces new interactive solutions to elevate health literacy and increase condition-specific treatment adherence
Utilizing augmented reality, artificial intelligence, and time-based visualization, Sharecare’s newest innovative tools help life sciences brands engage, educate, and activate...
RadioMedix Debuts Proprietary bench top ²¹²Pb Generator to Support Targeted Alpha Therapy Development
New bench top ²¹²Pb generator to expand clinical-grade isotope supply for targeted alpha therapy research and developmentHOUSTON, June 12, 2025...
Fortrea Adopts Limited-Duration Stockholder Rights Plan
Board Committed to Protecting Long-Term Value for All StockholdersDURHAM, N.C., June 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the...
Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative
GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a...
Fortrea Adopts Limited-Duration Stockholder Rights Plan
Board Committed to Protecting Long-Term Value for All StockholdersDURHAM, N.C., June 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the...
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapiesPITTSBURGH, June 12,...
Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative
GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a...
Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative
GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a...
Rakovina Therapeutics to Attend BIO International Convention to Advance Strategic Partnering Opportunities
VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”),...
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapiesPITTSBURGH, June 12,...
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapiesPITTSBURGH, June 12,...
AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen®
Patent portfolio now includes protection for manufacture, methods and compositions Provides AIM with patent protection for manufacturing Ampligen until 2041...
Rakovina Therapeutics to Attend BIO International Convention to Advance Strategic Partnering Opportunities
VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”),...